Les Meilleurs doctors pour votre Plasmaphérèse - TOP 19 des médecins

Eslie Perez apporte une expérience spécialisée dans les procédures dermatologiques et mini-invasives à sa pratique au Holistic Bio Spa®.

• Chef de l'enseignement à l'hôpital régional de Puerto Vallarta
• Certifiée en biomagnétisme pour les traitements holistiques
• Formée au laser fractionné et à l'IPL pour le rajeunissement du visage
• Expérience avec le Botox, les produits de comblement et la photothérapie UV

Dr. Siriporn Cheawchanwej is an aesthetic and anti-aging physician. She holds a Diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine and completed advanced training at the School of Anti-Aging and Regenerative Medicine and in Facial Design at Mae Fah Luang University.

Her international training includes Restylane seminars in Sweden (2006–2008) and the International Symposium of Botulinum Toxin in Korea. She also attended the Asia Pacific Rhinoplasty Expert Forum in Seoul, the International Congress of Minimal Invasive Plastic Surgery & Dermatology in Seoul, and IMCAS Asia 2009.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Le Dr Aygun Mammadova est spécialisée en neurologie intégrative et en ostéopathie, traitant les troubles complexes du système nerveux au Centre de médecine biologique – Centre de santé intégrative de Bakou.

• Formée à l'Université de médecine d'Azerbaïdjan et à l'Académie d'ostéopathie de Saint-Pétersbourg
• A participé à des congrès neurologiques internationaux en Allemagne, en Suisse et en Turquie
• Experte dans le traitement de la maladie de Parkinson, de la sclérose en plaques et des maladies dégénératives du système nerveux
• Utilise des méthodes ostéopathiques en complément de la neurologie conventionnelle pour des soins complets

Le Dr Topcular est spécialisé en neurologie avec une vaste expérience en plasmaphérèse à l'hôpital Florence Nightingale.

• Formé à la faculté de médecine Cerrahpaşa de l'université d'Istanbul
• A travaillé à la clinique neurologique de l'université de Bâle et au centre de recherche PharmaZentrum
• Exerce dans plusieurs sites de l'hôpital Florence Nightingale
• Membre de la faculté de médecine de neurologie de l'université Bilim d'Istanbul

Le Dr Amnon est spécialisé en plasmaphérèse au Centre Médical Sourasky (Ichilov) et propose des traitements avancés pour des pathologies complexes.

• Diplômé de l'Université de Tel Aviv en 1988
• Qualifié en médecine chinoise au Sri Lanka
• Expertise en stimulation du nerf vague et en plasmaphérèse

Dr. Pazit Beckerman is a nephrologist with over 24 years of clinical practice in Israel. She specializes in chronic kidney disease (CKD), acute kidney injury (AKI), hemodialysis and peritoneal dialysis, hypertension-related kidney disease, glomerular diseases and proteinuria, electrolyte disorders, and kidney involvement in systemic diseases.

She served as Acting Director in 2020, Deputy Director from 2018 to 2020, and Senior Physician in the Department of Nephrology at Sheba Medical Center. She also heads the Israeli Dialysis Registry.

Education and training: MD, Hebrew University–Hadassah. Nephrology residency, Hadassah. Fellowship in nephrology, Sheba Medical Center. Biomedical Computational Studies, Bar-Ilan University. Postdoctoral fellowship, University of Pennsylvania.

Her research focuses on AKI, immune-related kidney complications, and chronic kidney disease. She has authored many publications. She is a member of the American Society of Nephrology and a board member of the Israeli Society of Nephrology and Hypertension.

Dr. Zhang Yan Lin is a nationally recognized nephrologist with over 30 years in clinical care, teaching, and research. Dr. Zhang previously worked at the First Affiliated Hospital of Xiamen University.

Dr. Zhang took part in two NSFC projects, served as principal investigator for one Fujian Provincial NSFC project, and led two Xiamen Municipal key projects. Dr. Zhang is chief editor of one monograph and co-editor of three. Dr. Zhang has published more than 30 papers, including six in SCI journals.

Appointments: Deputy Chair of the Immunoadsorption and Cell Therapy Group of the Internal Medicine Branch of the Chinese Medical Association. Deputy Chair of the Nephrology Branch of the Asia-Pacific Academy of Medical and Biological Immunology. Standing Committee Member of the Nephrology and Dialysis Professional Committee of the China Non-Public Medical Institutions Association. Standing Committee Member of the East China Regional Nephrology Cooperation Committee.

Le Dr Buse Cagla Ary est spécialisée en neurologie, avec un accent particulier sur la plasmaphérèse à l'hôpital de district Medipol Acibadem.

• Neurologue certifiée avec plus de 8 ans de formation spécialisée
• Experte en troubles du mouvement et traitements neurologiques
• Membre de plusieurs sociétés internationales de neurologie
• Professeur adjoint à la faculté de médecine de l'université de Bahçeşehir
• Compétente dans les techniques de diagnostic neurologique avancé

Direction de plus de 100 essais cliniques nationaux et internationaux – Le Dr Arroyo est spécialisé en plasmaphérèse à Quironsalud Madrid.

• Chef du service de neurologie à l'hôpital universitaire Quironsalud depuis 2006
• Publication de 139 articles internationaux dans des revues de renom comme le New England Journal of Medicine
• Professeur de médecine à l'Université européenne de Madrid
• Chercheur principal dans la recherche sur la sclérose en plaques

Le Dr Romero Imbroda dirige l'unité de neurologie de Quirónsalud Marbella, se spécialisant dans les traitements avancés pour les pathologies neurologiques complexes.

• Chef des unités de neurologie des hôpitaux Quirónsalud Malaga et Marbella
• Auteur publié sur la sclérose en plaques et d'autres troubles neurologiques
• Membre du Conseil Européen de Neurologie
• Membre académique de l'Académie Royale de Médecine d'Andalousie Orientale
• Professeur à l'Université de Grenade

Le Dr Zengin est spécialisé en neurologie, avec un accent particulier sur les affections complexes telles que la Sclérose en Plaques et la Myasthénie, traitées à l'Hôpital International Medicalpoint.

• Diplômé de plusieurs universités prestigieuses, dont Dokuz Eylül et Başkent
• Membre des Académies Américaine et Européenne de Neurologie
• Expert en traitements avancés tels que la pompe à Apomorphine et la toxine botulique
• Expérience acquise dans des hôpitaux d'État à travers la Turquie

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Le Prof. Talip Asil est spécialisé en plasmaphérèse pour les affections neurologiques, formé dans les meilleures institutions, notamment l'Université de Calgary et l'Hôpital universitaire King Hamad.

• Plus de 20 ans d'expérience en neurologie
• Formation de boursier (fellowship) en soins des AVC à l'Université de Calgary
• Expert en techniques de neurologie interventionnelle
• Ancien professeur à la Faculté de médecine de Bezmialem
• Exerce à l'Hôpital universitaire Biruni